Micro-X Market update - First Sale of Rover
Filed with ASX · · 2 pages · English
Adelaide, Australia, 30th September 2020: Australian hi-tech company Micro-X Ltd (ASX:MX1) (Micro-X or the Company), a leader in cold cathode x-ray technology for health and security markets globally, is pleased to announce that today it has signed its first contract for sales of Micro-X’s second product, the Rover. Key Points $1.4M contract facilitated by World Health Organisation for Rover X-ray
Story so far
Earlier from Micro-X
- Appendix 4E and 2020 Annual Financial Report
- Appendix 4C - quarterly
- Micro-X Receives Rover FDA 510(k) Approval
- Micro-X Market Update - Submission of Rover FDA 510 (k)
- Market update - Micro-X Rover Testing Complete
Later from Micro-X
- Micro-X Quarterly Cash Flow and Activities Statement
- Market Update DHS US$4M Airport Security Award
- Micro-X Amended Nano Distribution Agreement
- MX1 - $1.3M Rover contract with Australia Defence Force
- MX1 - Receipt of $1.95M R&D Rebate
Follow Micro-X into a list and get an email when it puts out news.
Follow Micro-X